GRI Archived Articles
GRI Bio, Inc. (NASDAQ:GRI): Unlocking the Power of Natural Killer T Cells to Transform Inflammatory, Fibrotic, and Autoimmune Diseases
Published on March 13, 2025
George Risk Industries, Inc. (RSKIA): A Diversified Manufacturer Navigating Challenging Times
Published on November 17, 2024
GRI Bio (NASDAQ: GRI) - A Promising Biotech Tackling Inflammatory, Fibrotic and Autoimmune Diseases
Published on September 24, 2024